Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMT4D: DMT With or Without Propofol in Major Depression
NCT06927076Recruiting
- Sponsor
- University Hospital Basel
- Start
- Aug 2025
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of DMT in major depressive disorder (MDD) (4 arms), sponsored by University Hospital Basel. Primary endpoint: Montgomery-Åsberg Depression Rating Scale at day 14. Started Aug 2025; status: recruiting.
02
Drugs
DMT
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06927076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06927076.